Germanies „fast track“ to More Access for Health Care Apps

In recent months, there has been plenty of buzz generated around the Digitale Versorgung Gesetz (DVG), a new law promising a fast track to reimbursement of digital solutions within the German Statutory Healthcare System (SHI) -- and that buzz is for...


Aignostics raises €5m Seed Round to advance AI-powered pathology


Aignostics, a spin-off from Charité – Universitätsmedizin Berlin and the Berlin Institute of Health, pioneering computational pathology for pharmaceutical research and diagnostics, has announced today the closing of €5m in seed round funding....


Europe’s Largest Initiative Launches to Accelerate Therapy Development for COVID-19 and Future Coronavirus Threats

CARE (Corona Accelerated R&D in Europe), supported by Europe’s Innovative Medicines Initiative (IMI), is the largest undertaking of its kind dedicated to discovering and developing urgently needed treatment options for COVID-19.


The initiative is...


Targeted deep brain stimulation to treat obsessive-compulsive disorder

A group of researchers from Charité – Universitätsmedizin Berlin have further refined the use of deep brain stimulation in the treatment of obsessive-compulsive disorder. By accurately localizing electrode placement in the brains of patients, the...


Myelo Therapeutics Closes Financing Round and Gains Strong Backing of Eckert & Ziegler Group

Myelo Therapeutics GmbH, a clinical-stage pharmaceutical company focused on developing therapies for cancer supportive care and medical countermeasures (MCM), announced today the successful closing of a multi-million Euro financing round, following...



Infection with the novel coronavirus SARS-CoV-2 follows a highly variable course: some of those infected do not even notice it, while others become so seriously ill that their lives are placed at risk. Scientists from the Berlin Institute of Health...


SCIENION and Randox expand collaboration to transform high throughput biochip manufacturing

- Multiyear alliance underpins Randox commitment to increase biochip manufacturing to transform rapid diagnostic testing

- SCIENION AG to integrate its precision dispensing technology to enable Randox to scale-up Biochip manufacturing across the...


Takeda – International Tradition in the Capital Region

The history of the pharmaceutical company Takeda from Japan has been 239 years, for 39 years

Takeda is active in Germany. During this time it has acquired and developed the current locations in Berlin, Oranienburg, Konstanz and Singen. In...


Rare Diseases in the Capital Region: an Overview of Activities and Challenges

The development of drugs for the treatment of rare diseases is difficult, as is the development of safe methods of diagnosis. Although the number of patients suffering from rare diseases is relatively large, the estimated 8,000 different rare...


How the German Capital Region is evolving during Sars-Cov-2


In late January the Sars-Cov-2 pandemic officially arrived and started spreading across Germany. Since then – like in almost every other country globally - every new day feels completely new, uncertain and presents previously unknown challenges,...

Show more items